U.S. Markets closed

See what the IHS Markit Score report has to say about Sarepta Therapeutics Inc.

IHS Markit

Sarepta Therapeutics Inc


Score: Negative (18)

9 days at current score.

Downgraded from Neutral on April 5th 2018

View full report here!


  • This company ranked negatively compared to the Healthcare sector despite only 1 negative IHS Markit Category
  • Bearish sentiment is high

Bearish sentiment

Short interest | Negative

Short interest is high for SRPT with between 15 and 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting SRPT. However, the last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment.

Money flow

ETF/Index ownership | Neutral

ETF activity is neutral. The net inflows of $471 million over the last one-month into ETFs that hold SRPT are not among the highest of the last year and have been slowing.

Economic sentiment

PMI by IHS Markit | Neutral

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however.

Credit worthiness

Credit default swap

CDS data is not available for this security.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.